Search News

Corporate Industry Technology Medical Updates

extracorporeal ventricular assist device

Technology
magAssist's extracorporeal artificial heart product made the first public appearance at an international academic conference 2019-11-28
Medical Updates
Rapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery 2025-04-12
Medical Updates
High-Risk Coronary Revascularization Supported by MoyoAssist® Magnetic Levitation 2025-04-02
Corporate
magAssist Presents MoyoAssist® at ESAO 2024, Advancing Global Dialogue in Artificial Organ Technology 2024-09-26
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Corporate
magAssist, Founding Member of “Suzhou-Soochow Overseas Chinese Entrepreneurship and Innovation Alliance”, Facilitates Innovation and Entrepreneurship of Returned Students 2023-01-16
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06

Tabs： medical device, percutaneous intervention, Mechatronics, How to Choose Extra-VAD or ECMO, high-end medical devices, Chinese heart failure patients, cardiovascular disease patients, the extracorporeal maglev artificial heart, extracorporeal blood pumps, high-end innovative medical device,